Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank50
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-1106.72%
↑ 36% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-1726.41%
Historical baseline
PeriodValueYoY Change
2025-1106.72%+66.7%
2024-3326.01%-489.1%
2023-564.61%+18.2%
2022-690.63%+76.5%
2021-2944.07%-